CDNA logo

CDNA CareDx, Inc

NASDAQ Global Market · Medical - Diagnostics & Research · Healthcare

$74.75
+1.03 (+1.40%)

CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employing …

Market Cap: $3.93Bwww.caredx.com

Price

No data yet.

Social Signal Score

44
5d
—
30d
45
12 mentions
—
60d
44
13 mentions
—
90d
43
15 mentions
—
news: 12 · marketaux: 1 · rss: 2

Analyst Ratings

14 analysts
Buyconsensus
Strong Buy 0Buy 11Hold 3Sell 0Strong Sell 0
Avg price target$80.2+7.3%
Low $46Median $92High $100
Current Consensus

Revenue

$139.36M+1183.26%
$10.86M$53.69M$96.53M$139.36M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.30
$-0.30–$-0.29
4 analysts
FY2026
$1.78
$1.76–$1.79
4 analysts
FY2027
$1.56-12% YoY
$1.49–$1.62
5 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
John Walter Hanna Jr.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
763
Beta
2.49
Country
US
Piotroski score
6 / 9 (Middling)
Altman Z-score
13.45
www.caredx.com